Dako, Amgen to develop test, 4/14
April 2014—Dako and Amgen will develop a molecular diagnostic test using Dako’s IQFISH hybridization buffer.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
Benchtop chemistry analyzer, 4/14
April 2014—Vital Diagnostics launched the Eon 300 benchtop scalable chemistry analyzer for small to midsize physician office labs, satellite labs, and small hospital labs.
Multianalyte quality controls, 4/14
April 2014—Bio-Rad Laboratories has a comprehensive line of multianalyte quality controls now available in Siemens Dimension Vista vials for use on Siemens Dimension Vista Intelligent Lab Systems.
New CLSI editions: M100-S24, eM100, 4/14
April 2014—The Clinical and Laboratory Standards Institute released a new edition of its document M100-S24: Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement, which provides updated tables for the CLSI antimicrobial susceptibility testing standards M02-A11, M07-A9, and M11-A8.
Horizon, Desktop Genetics to collaborate, 4/14
April 2014—Horizon Discovery entered into a collaboration agreement with Desktop Genetics for development of a CRISPR design platform. Horizon will use the platform to identify the best guide-RNAs in the human genome for each gene editing task, as part of its GENESIS suite of gene editing technologies.
Multiplexed DNA analysis, 4/14
April 2014—AutoGenomics launched the Infinity High Throughput System, which provides semiautomated multiplexed DNA analysis in an open front-end system with a flexible and scalable throughput, from 96 to 3,456 samples tested in just one shift.
Anatomic pathology reference laboratory, 4/14
April 2014—PAML and CellNetix launched a joint venture anatomic pathology reference laboratory separately branded as Symbiodx. A major focus of this venture will be on molecular oncology with a broad offering of molecular tests, including next-generation sequencing, IHC, flow cytometry, and cytogenetics.
MPLN buys MiSeqDx, 4/14
April 2014—Molecular Pathology Laboratory Network, of Maryville, Tenn., acquired the Illumina MiSeqDx, a next-generation sequencing system cleared by the FDA for targeted sequencing of human genomic DNA.
Partners: UCSF, Quest, 4/14
April 2014—UC San Francisco and Quest Diagnostics formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine for improved patient care, treatment, and outcomes.
DNA, RNA stabilization reagents
April 2014—In a licensing agreement between Biomatrica and ATCC, Biomatrica will supply DNAstable and RNAstable reagents for the stabilization of DNA and RNA standards.